[1] E. Buzzetti, M. Pinzani, E. A. Tsochatzis. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism: clinical and experimental, 2016, 65(8): 1038-1048.
[2] Singh V, Chassaing B, Zhang L, San Yeoh B, Xiao X, Kumar M, Baker MT, Cai J, Walker R, Borkowski K. Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice. Cell Metab, 2015, 22(6):983-996.
[3] M. Mouzaki, E. M. Comelli, B. M. Arendt, J. Bonengel, S. K. Fung, S. E. Fischer, I. D. McGilvray, J. P. Allard. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology, 2013, 58(1): 120-127
[4] Natividad JM, Agus A, Planchais J, Lamas B, Jarry AC, Martin R, Michel ML, Chong-Nguyen C, Roussel R, Straube M. Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome. Cell Metabm, 2018, 28(5):737-749 e734.
[5] Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature, 2019, 575(7783):505-511.
[6] Zhao M, Zhao L, Xiong X, He Y, Huang W, Liu Z, Ji L, Pan B, Guo X, Wang L. TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits gamma-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice. Gastroenterology, 2020, 158(8):2266-2281 e2227.
[7] S. Wu, S. Yano, J. Chen, A. Hisanaga, K. Sakao, X. He, J. He, D. X. Hou. Polyphenols from Lonicera caerulea L. Berry Inhibit LPS-Induced Inflammation through Dual Modulation of Inflammatory and Antioxidant Mediators. Journal of agricultural and food chemistry, 2017, 65(25): 5133-5141.
[8] Shusong Wu, Xi He, Xiaosong Wu, Si Qin, Jianhua He, Shirui Zhang, De-Xing Hou. Inhibitory effects of blue honeysuckle (Lonicera caerulea L) on adjuvant-induced arthritis in rats: Crosstalk of anti-inflammatory and antioxidant effects. Journal of Functional Foods, 2015, 17: 514-523.
[9] C. Xu, Y. Yagiz, W. Y. Hsu, A. Simonne, J. Lu, M. R. Marshall. Antioxidant, antibacterial, and antibiofilm properties of polyphenols from muscadine grape (Vitis rotundifolia Michx.) pomace against selected foodborne pathogens. Journal of agricultural and food chemistry, 2014, 62(28): 6640-6649.
[10] S. Wu, S. Yano, A. Hisanaga, X. He, J. He, K. Sakao, D. X. Hou. Polyphenols from Lonicera caerulea L. berry attenuate experimental nonalcoholic steatohepatitis by inhibiting proinflammatory cytokines productions and lipid peroxidation. Molecular nutrition & food research, 2017, 61(4): 1600858.
[11] S. Wu, R. Hu, H. Nakano, K. Chen, M. Liu, X. He, H. Zhang, J. He, D. X. Hou. Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet. Molecules, 2018, 23(12): 3213.
[12] C. Czank, A. Cassidy, Q. Zhang, D. J. Morrison, T. Preston, P. A. Kroon, N. P. Botting, C. D. Kay. Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study. The American journal of clinical nutrition, 2013, 97(5): 995-1003.
[13] R. M. de Ferrars, C. Czank, Q. Zhang, N. P. Botting, P. A. Kroon, A. Cassidy, C. D. Kay. The pharmacokinetics of anthocyanins and their metabolites in humans. British journal of pharmacology, 2014, 171(13): 3268-3282.
[14] H. P. Amin, C. Czank, S. Raheem, Q. Zhang, N. P. Botting, A. Cassidy, C. D. Kay. Anthocyanins and their physiologically relevant metabolites alter the expression of IL-6 and VCAM-1 in CD40L and oxidized LDL challenged vascular endothelial cells. Molecular nutrition & food research, 2015, 59(6): 1095-1106.
[15] J. Tan, Y. Li, D. X. Hou, S. Wu. The Effects and Mechanisms of Cyanidin-3-Glucoside and Its Phenolic Metabolites in Maintaining Intestinal Integrity. Antioxidants, 2019, 8(10): 479; doi:10.3390/antiox8100479.
[16] Gene, Igawa, Mika, Casey, Etsuko, Sawabe, Yoko, Nukui, Shu, Okugawa. Comparison of agar dilution and broth microdilution methods for Clostridium difficile antimicrobial susceptibility testing. Journal of Global Antimicrobial Resistance, 2016.
[17] Kaiser S J, Mutters N T, Blessing B. Natural isothiocyanates express antimicrobial activity against developing and mature biofilms of Pseudomonas aeruginosa. Fitoterapia, 2017, 119:57-63.
[18] Gong Shenhai,Yan Zhengzheng,Liu Zhanguo et al. Intestinal Microbiota Mediates the Susceptibility to Polymicrobial Sepsis-Induced Liver Injury by Granisetron Generation in Mice.[J] .Hepatology, 2019, 69: 1751-1767.
[19] Dr Matthews. Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985, 28(7): 412.
[20] E. Ruiz, J. M. Avila, T. Valero, S. del Pozo, P. Rodriguez, J. Aranceta-Bartrina, A. Gil, M. Gonzalez-Gross, R. M. Ortega, L. Serra-Majem, G. Varela-Moreiras. Energy Intake, Profile, and Dietary Sources in the Spanish Population: Findings of the ANIBES Study. Nutrients, 2015, 7(6): 4739-4762.
[21] J. O. Hill, H. R. Wyatt, J. C. Peters. Energy balance and obesity. Circulation, 2012, 126(1): 126-132.
[22] Q. Zhao, F. Liu, Y. Wang, H. Lai, Q. Zhao, J. Luo, Y. Ma, X. Li, Y. Yang. LDL-C:HDL-C ratio and common carotid plaque in Xinjiang Uygur obese adults: a cross-sectional study. BMJ Open, 2018, 8(10): e022757.
[23] A. M. Matias, W. M. Estevam, P. M. Coelho, D. Haese, Jbbs Kobi, A. P. Lima-Leopoldo, A. S. Leopoldo. Differential Effects of High Sugar, High Lard or a Combination of Both on Nutritional, Hormonal and Cardiovascular Metabolic Profiles of Rodents. Nutrients, 2018, 10(8): 1071.
[24] H. Malhi, G. J. Gores. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Seminars in liver disease, 2008, 28(4): 360-369.
[25] Bishara J, Farah R, Mograbi J, Khalaila W, Abu-Elheja O, Mahamid M, Nseir W. Obesity as a risk factor for Clostridium difficile infection. Clin Infect Dis, 2013, 57: 489-493.
[26] K. Forslund, F. Hildebrand, T. Nielsen, G. Falony, E. Le Chatelier, S. Sunagawa, E. Prifti, S. Vieira-Silva, V. Gudmundsdottir, H. K. Pedersen, M. Arumugam, K. Kristiansen, A. Y. Voigt, H. Vestergaard, R. Hercog, P. I. Costea, J. R. Kultima, J. Li, T. Jorgensen, F. Levenez, J. Dore, H. I. T. consortium Meta, H. B. Nielsen, S. Brunak, J. Raes, T. Hansen, J. Wang, S. D. Ehrlich, P. Bork, O. Pedersen. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature, 2015, 528(7581): 262-266.
[27] M. Garcia-Solache, L. B. Rice. The Enterococcus: a Model of Adaptability to Its Environment. Clinical microbiology reviews, 2019, 32(2): e00058-18.
[28] P. Zhou, X. Yang, Z. Yang, W. Huang, J. Kou, F. Li. Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats. Molecules, 2019, 24(7): 1268.
[29] S. Tims, C. Derom, D. M. Jonkers, R. Vlietinck, W. H. Saris, M. Kleerebezem, W. M. de Vos, E. G. Zoetendal. Microbiota conservation and BMI signatures in adult monozygotic twins. The ISME journal, 2013, 7(4): 707-717.
[30] M. U. Sohail, A. Althani, H. Anwar, R. Rizzi, H. E. Marei. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus. Journal of diabetes research, 2017, 2017: 9631435.
[31] Mouzaki, E. M. Comelli, B. M. Arendt, J. Bonengel, S. K. Fung, S. E. Fischer, I. D. McGilvray, J. P. Allard. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology, 2013, 58(1): 120-127.
[32] G. Musso, R. Gambino, M. Cassader. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Progress in lipid research, 2009, 48(1): 1-26.
[33] Forstner G G, Tanaka K, Isselbacher K J. Lipid composition of the isolated rat microvillus membrane. Biochemical Journal, 1968, 109(1): 51-59.
[34] I. Treede, A. Braun, P. Jeliaskova, T. Giese, J. Fullekrug, G. Griffiths, W. Stremmel, R. Ehehalt. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC gastroenterology, 2009, 9: 53.
[35] J. L. Sherriff, T. A. O'Sullivan, C. Properzi, J. L. Oddo, L. A. Adams. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Advances in nutrition, 2016, 7(1): 5-13.
[36] D. Xie, V. Choudhary, M. Seremwe, J. G. Edwards, A. Wang, A. C. Emmons, K. A. Bollag, M. H. Johnson, W. B. Bollag. Soy Phosphatidylglycerol Reduces Inflammation in a Contact Irritant Ear Edema Mouse Model In Vivo. The Journal of pharmacology and experimental therapeutics, 2018, 366(1): 1-8.
[37] Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review. Adv Nutr, 2020, 11: 77-91.
[38] J. A. Chavez, S. A. Summers. A ceramide-centric view of insulin resistance. Cell metabolism, 2012, 15(5): 585-594.
[39] M. Pagadala, T. Kasumov, A. J. McCullough, N. N. Zein, J. P. Kirwan. Role of ceramides in nonalcoholic fatty liver disease. Trends in endocrinology and metabolism: TEM, 2012, 23(8): 365-371.